RxSight, Inc. (RXST)

SEC filing

RxSight, Inc.

RXST · CIK 1111485

4 · Sep 9, 2026 · Chief Financial Officer Wilterding Mark was granted 258.77K Stock Option (right to buy); reported 258.77K Stock Option (right to buy)

Chief Financial Officer Wilterding Mark was granted 258.77K Stock Option (right to buy); reported 258.77K Stock Option (right to buy)

Filed: Sep 9, 2026
Accession: 0001193125-26-386841
Filer: RxSight, Inc.

View on SEC.gov All SEC filings

Could not load the primary document from EDGAR (temporary SEC rate limit or timeout). Refresh in a few seconds, or use View on SEC.gov.